MYELOPROLIFERATIVE NEOPLASMS TREATMENT MARKET ANALYSIS

Table of Contents

1. Research Objective and Assumption
   • Research Objectives
   • Assumptions
   • Abbreviations
2. Market Purview
   • Report Description
     • Market Definition and Scope
   • Executive Summary
     • Market Snippet, By Disease Type
     • Market Snippet, By Drug Class
     • Market Snippet, By Distribution Channel
     • Market Snippet, By Region
   • Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
   • Market Dynamics
     • Drivers
     • Restraints
     • Market Opportunities
   • Impact Analysis
   • Regulatory Scenario
   • Epidemiology
   • Merger, Acquisition, and Collaborations
   • Regulatory Scenario
   • Key Developments
   • PEST Analysis
4. Global Myeloproliferative Neoplasms Treatment Market – COVID-19 Impact Analysis
   • Economic Impact
   • COVID-19 Epidemiology
   • Impact on Supply and Demand
5. Global Myeloproliferative Neoplasms Treatment Market, By Disease Type, 2018-2030, (US$ Bn)
   • Introduction
     • Market Share Analysis, 2023 and 2030 (%)
     • Y-o-Y Growth Analysis, 2019–2030
     • Segment Trends
   • Essential Thrombocythemia (ET)
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2018 – 2030, (US$ Bn)
     • Segment Trends
   • Myelofibrosis (MF)
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2018 – 2030, (US$ Bn)
     • Segment Trends
   • Polycythemia Vera (PV)
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2018 – 2030, (US$ Bn)
     • Segment Trends
6. Global Myeloproliferative Neoplasms Treatment Market, By Drug Class, 2018 – 2030, (US$ Bn)
   • Introduction
     • Market Share Analysis, 2023 and 2030 (%)
     • Y-o-Y Growth Analysis, 2019–2030
     • Segment Trends
   • Tyrosine Kinase Inhibitors
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2018 – 2030, (US$ Bn)
     • Segment Trends
   • Janus Kinase Inhibitors
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2018 – 2030, (US$ Bn)
     • Segment Trends
   • Antimetabolites
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2018 – 2030, (US$ Bn)
     • Segment Trends
   • Others
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2018 – 2030, (US$ Bn)
     • Segment Trends
7. Global Myeloproliferative Neoplasms Treatment Market, By Distribution Channel, 2018 – 2030, (US$ Bn)
   • Introduction
     • Market Share Analysis, 2023 and 2030 (%)
     • Y-o-Y Growth Analysis, 2019–2030
     • Segment Trends
   • Hospital Pharmacies
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2018 – 2030, (US$ Bn)
   • Retail Pharmacies
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2018 – 2030, (US$ Bn)
   • Online Pharmacies
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2018 – 2030, (US$ Bn)
8. Global Myeloproliferative Neoplasms Treatment Market, By Region, 2018 – 2030, (US$ Bn)
   • Introduction
     • Market Share Analysis, 2023 and 2030 (%)
     • Y-o-Y Growth Analysis, 2019–2030
     • Segment Trends
   • North America
     • Introduction
     • Market Size and Forecast, Y-o-Y Growth and By Disease Type, 2018 –2030, (US$ Bn)
     • Market Size and Forecast, Y-o-Y Growth and By Drug Class, 2018 –2030, (US$ Bn)
     • Market Size and Forecast, Y-o-Y Growth and By Distribution Channel, 2018–2030, (US$ Bn)
     • Market Size and Forecast, By Country, Y-o-Y Growth and By Country,  2018 –2030, (US$ Bn)
       • U.S.
       • Canada
   • Europe
     • Introduction
     • Market Size and Forecast, Y-o-Y Growth and By Disease Type, 2018 –2030, (US$ Bn)
     • Market Size and Forecast, Y-o-Y Growth and By Drug Class, 2018 –2030, (US$ Bn)
     • Market Size and Forecast, Y-o-Y Growth and By Distribution Channel, 2018–2030, (US$ Bn)
     • Market Size and Forecast, By Country, Y-o-Y Growth and By Country,  2018 –2030, (US$ Bn)
       • U.K.
       • Germany
       • Italy
       • France
       • Spain
       • Russia
       • Rest of Europe
   • Asia Pacific
     • Introduction
     • Market Size and Forecast, Y-o-Y Growth and By Disease Type, 2018 –2030, (US$ Bn)
     • Market Size and Forecast, Y-o-Y Growth and By Drug Class, 2018 –2030, (US$ Bn)
     • Market Size and Forecast, Y-o-Y Growth and By Distribution Channel, 2018–2030, (US$ Bn)
     • Market Size and Forecast, By Country, Y-o-Y Growth and By Country,  2018 –2030, (US$ Bn)
       • China
       • India
       • Japan
       • ASEAN
       • Australia
       • South Korea
       • Rest of Asia Pacific
   • Latin America
     • Introduction
     • Market Size and Forecast, Y-o-Y Growth and By Disease Type, 2018 –2030, (US$ Bn)
     • Market Size and Forecast, Y-o-Y Growth and By Drug Class, 2018 –2030, (US$ Bn)
     • Market Size and Forecast, Y-o-Y Growth and By Distribution Channel, 2018–2030, (US$ Bn)
     • Market Size and Forecast, By Country, Y-o-Y Growth and By Country,  2018 –2030, (US$ Bn)
       • Brazil
       • Mexico
       • Argentina
       • Rest of Latin America
   • Middle East
     • Introduction
     • Market Size and Forecast, Y-o-Y Growth and By Disease Type, 2018 –2030, (US$ Bn)
     • Market Size and Forecast, Y-o-Y Growth and By Drug Class, 2018 –2030, (US$ Bn)
     • Market Size and Forecast, Y-o-Y Growth and By Distribution Channel, 2018–2030, (US$ Bn)
     • Market Size and Forecast, By Country, Y-o-Y Growth and By Country,  2018 –2030, (US$ Bn)
       • GCC
       • Israel
       • Rest of Middle East
   • Africa
     • Introduction
     • Market Size and Forecast, Y-o-Y Growth and By Disease Type, 2018 –2030, (US$ Bn)
     • Market Size and Forecast, Y-o-Y Growth and By Drug Class, 2018 –2030, (US$ Bn)
     • Market Size and Forecast, Y-o-Y Growth and By Distribution Channel, 2018–2030, (US$ Bn)
     • Market Size and Forecast, Y-o-Y Growth and By Region/Country,  2018 –2030, (US$ Bn)
       • North Africa
       • Central Africa
       • South Africa
9. Competitive Landscape
   • Company Profiles
     • Novartis AG
       • Company Overview
       • Product Portfolio
       • Key Highlights
       • Financial Overview
       • Strategies
     • PharmaEssentia Corporation
       • Company Overview
       • Product Portfolio
       • Key Highlights
       • Financial Overview
       • Strategies
     • Bristol Myers Squibb
       • Company Overview
       • Product Portfolio
       • Key Highlights
       • Financial Overview
       • Strategies
     • Pfizer, Inc.
       • Company Overview
       • Product Portfolio
       • Key Highlights
       • Financial Overview
       • Strategies
     • Takeda Pharmaceutical Company Limited
       • Company Overview
       • Product Portfolio
       • Key Highlights
       • Financial Overview
       • Strategies
     • Incyte
       • Company Overview
       • Product Portfolio
       • Key Highlights
       • Financial Overview
       • Strategies
     • Johnson & Johnson
       • Company Overview
       • Product Portfolio
       • Key Highlights
       • Financial Overview
       • Strategies
     • Teva Pharmaceutical Industries Ltd
       • Company Overview
       • Product Portfolio
       • Key Highlights
       • Financial Overview
       • Strategies
     • F. Hoffmann-La Roche AG
       • Company Overview
       • Product Portfolio
       • Key Highlights
       • Financial Overview
       • Strategies
     • Gamida Cell
       • Company Overview
       • Product Portfolio
       • Key Highlights
       • Financial Overview
       • Strategies
     • Sierra Oncology, Inc
       • Company Overview
       • Product Portfolio
       • Key Highlights
       • Financial Overview
       • Strategies
     • CTI BioPharma Corp
       • Company Overview
       • Product Portfolio
       • Key Highlights
       • Financial Overview
       • Strategies
     • Imago BioSciences
       • Company Overview
       • Product Portfolio
       • Key Highlights
       • Financial Overview
       • Strategies
     • AbbVie Inc
       • Company Overview
       • Product Portfolio
       • Key Highlights
       • Financial Overview
       • Strategies
     • Constellation Pharmaceuticals
       • Company Overview
       • Product Portfolio
       • Key Highlights
       • Financial Overview
       • Strategies
10. Section
    • References
    • Research Methodology
    • About us and Sales Contact

*Browse 36 market data tables and 26 figures on “Global Myeloproliferative Neoplasm Treatment Market” – Global forecast to 2030